BrainsWay announces Avner Lushi to the Board of Directors and its Audit Committee

– ISRAEL, Jerusalem –  BrainsWay Ltd. (NASDAQ: BWAY | TASE: BWAY), a commercial-stage medical device company focused on the development and sale of non-invasive neuromodulation products using its proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and Obsessive Compulsive Disorder, today announced that Avner Lushi will be joining its board of directors and will also serve as a member of its audit committee.…

Can-Fite BioPharma welcomes Golan Bitton to its Board of Directors

– ISRAEL, Petah Tikva –  Can-Fite BioPharma Ltd. (NYSE: CANF | TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that bind specifically to the A3 adenosine receptor, addressing cancer, liver and inflammatory diseases, today announced that Golan Bitton, CEO of Univo Pharmaceuticals (TASE: UNVO), was elected as a board member to Can-Fite at its recent annual general meeting.…